FOR RESEARCH PURPOSES ONLYNot for human or veterinary consumption or use.This page is educational research context—not medical advice.
← Back to catalog

MTC · RESEARCH PROFILE

MOTS-C

Mitochondrial-derived peptide

A 16-amino-acid mitochondrial-derived peptide studied in early research involving mitochondrial communication, metabolism, and cellular stress responses.

RESEARCH FOCUSMetabolic & cellular-stress signaling
VIAL SIZE20mg
LOCAL PRICE$85
Representative Trenix Labs MOTS-C 20mg research vial presentation
REPRESENTATIVE SAMPLE

KEY HIGHLIGHTS

Start with the research context.

01

16-amino-acid mitochondrial peptide

02

Folate–purine–AMPK pathway research

03

Mitochondrial-to-nuclear signaling

04

Metabolic-stress models

05

Limited human exposure data

EXPLORE MOTS-C

Understand the molecule.
Understand the limits.

01

What is MOTS-C?

MOTS-C is a 16-amino-acid peptide encoded within a short open reading frame of mitochondrial 12S rRNA. It is part of a broader research category called mitochondrial-derived peptides—small signals studied for how mitochondria communicate cellular energy and stress status to the rest of the cell.

02

How does it work in research?

Early studies connect MOTS-C with folate and purine metabolism, accumulation of AICAR, and activation of AMPK, a cellular energy sensor. Under metabolic stress, MOTS-C has also been observed to move into the nucleus in an AMPK-dependent process and interact with stress-responsive gene programs. These mechanisms were established mainly in cell and animal models.

03

Why do researchers study it?

Researchers use MOTS-C to investigate mitochondrial-to-nuclear communication, glucose utilization, metabolic flexibility, stress adaptation, and age-associated changes. Typical models measure metabolites, AMPK-linked signaling, nuclear localization, gene expression, insulin sensitivity, or tissue-specific responses.

04

What sets it apart?

MOTS-C is encoded by mitochondrial rather than nuclear DNA, making it a useful tool for studying retrograde signaling from mitochondria to the nucleus. Its proposed activity links a metabolic intermediate pathway with transcriptional responses, but the direction and magnitude of effects can vary by cell type and experimental stress.

EVIDENCE BOUNDARY

What the research
doesn’t establish.

Most mechanistic evidence comes from cells and animals. FDA has noted a lack of identified human exposure data for MOTS-C products. Human pharmacokinetics, dose-response, long-term safety, and the comparability of synthetic products to endogenous MOTS-C remain insufficiently characterized.

ImportantThis information describes areas of scientific study. It is not evidence that a product is safe or effective, and it does not provide directions for use.

READ THE SOURCES

Trace the research.

These links provide context for the pathways and limitations described above. Studies of an ingredient or related molecule do not validate a specific Trenix batch or blend.

LOCAL FOLLOW-UP

Interested in MOTS-C?

Submit a research-product request and our local team will follow up about availability and documentation.

Start a request ↗